Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.57x is 195% above its 5-year average of -0.60x, near the high end of its 5-year range (-11.19x–1.34x).
602.34% above its 12-month average of -0.11x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): 0.33x.
INTEREST COVERAGE RATIO
0.57x
INTEREST COVERAGE RATIO AVG TTM
-0.11x
INTEREST COVERAGE RATIO AVG 3Y
-0.50x
INTEREST COVERAGE RATIO AVG 5Y
-0.60x
INTEREST COVERAGE RATIO AVG 10Y
-0.76x
INTEREST COVERAGE RATIO AVG 15Y
3.32x
INTEREST COVERAGE RATIO AVG 20Y
4.75x
CURRENT VS TTM AVG
+602.34%
CURRENT VS 3Y AVG
+213.21%
CURRENT VS 5Y AVG
+195.31%
CURRENT VS 10Y AVG
+174.74%
CURRENT VS 15Y AVG
-82.83%
CURRENT VS 20Y AVG
-88.01%
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
+111.42%
vs the sector median at left
Lifecore Biomedical, Inc.
Market Cap
$243.81M
Interest Coverage Ratio
0.57x
TTM Avg
-0.11x
3Y Avg
-0.50x
5Y Avg
-0.60x
Market Cap
$243.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.85M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$238.61M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.77M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.81M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$250.48M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.77M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $243.81M | 0.57x | -0.11x | -0.50x | -0.60x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.95M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.85M | N/A | 0.97x | 1.45x | 67.07x |
| Invivyd, Inc. (IVVD)vs › | $243.08M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $238.61M | -1280.37x | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $235.77M | -2.74x | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $236.81M | -1.08x | 0.39x | 0.39x | 0.20x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | -530.37x | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.77M | 0.97x | 0.97x | 0.97x | 0.97x |
| BioAge Labs Inc. (BIOA)vs › | $232.73M | -133.11x | N/A | N/A | N/A |
Interest Coverage
0.6x
Debt/Equity
9.64
Current Ratio
3.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.33x |
| 2026-06-30 | 0.33x |
| 2026-03-31 | -0.64x |
| 2025-09-30 | -0.48x |
| 2025-05-25 | 0.96x |
| 2025-02-23 | -1.65x |
| 2024-11-24 | -0.36x |
| 2024-08-25 | -2.16x |
| 2024-05-26 | 0.37x |
| 2024-02-25 | -0.21x |
| 2023-11-26 | -0.36x |
| 2023-08-27 | -2.19x |
| 2023-05-28 | -0.31x |
| 2023-02-26 | -1.35x |
| 2022-11-27 | -1.48x |
| 2022-08-28 | -1.01x |
| 2022-05-29 | -11.19x |
| 2022-02-28 | -2.09x |
| 2021-11-30 | 1.34x |
| 2021-08-31 | -0.41x |
| 2021-05-31 | 0.25x |
| 2021-02-28 | 0.83x |
| 2020-11-30 | -0.48x |
| 2020-08-31 | -4.01x |
| 2020-05-31 | -4.17x |
| 2020-02-29 | -6.79x |
| 2019-11-30 | -2.78x |
| 2019-08-31 | -2.11x |
| 2019-05-31 | 1.27x |
| 2019-02-28 | 1.49x |
| 2018-11-30 | -0.81x |
| 2018-08-31 | -0.59x |
| 2018-05-31 | 15.09x |
| 2018-02-28 | 6.04x |
| 2017-11-30 | -1.15x |
| 2017-08-31 | 6.24x |
| 2017-05-31 | 6.20x |
| 2017-02-28 | 10.82x |
| 2016-11-30 | 8.59x |
| 2016-08-31 | 8.38x |
| 2016-05-31 | 12.60x |
| 2016-02-29 | -69.47x |
| 2015-11-30 | 6.39x |
| 2015-08-31 | 7.84x |
| 2015-05-31 | 13.37x |
| 2015-02-28 | 9.47x |
| 2014-11-30 | 8.25x |
| 2014-08-31 | 9.23x |
| 2014-05-31 | 13.47x |
| 2014-02-28 | 24.95x |
| 2013-11-30 | 7.28x |
| 2013-08-31 | 4.58x |
| 2013-05-31 | 8.53x |
| 2013-02-28 | 13.67x |
| 2012-11-30 | 22.28x |
| 2012-08-31 | 5.55x |
| 2012-05-31 | 7.27x |
| 2012-02-29 | 26.37x |
| 2011-11-30 | 25.82x |
| 2011-08-31 | 16.32x |
| 2011-05-31 | -16.79x |
| 2011-02-28 | 19.11x |
| 2010-11-30 | 16.88x |
| 2010-08-31 | 17.33x |
| 2010-05-31 | 41.39x |
| 2010-02-28 | 685.50x |
| 2009-11-30 | 573.25x |
| 2009-08-31 | 3361.00x |
| 2009-05-31 | 1626.00x |
| 2009-02-28 | 1273.50x |
| 2008-08-31 | 2279.50x |
| 2008-02-29 | 1024.40x |
| 2006-11-30 | 73.50x |
| 2005-11-30 | -221.25x |
| 2005-08-31 | -8.56x |
| 2005-05-31 | 13.73x |
| 2004-11-30 | -6.68x |
| 2004-05-31 | 12.35x |
| 2003-11-30 | -6.83x |
| 2003-08-31 | -3.54x |
| 2002-10-31 | -11.12x |
